Conventional drug information guides provide data only for drugs used individually. But highly effective combination treatment regimens require complex dosing schedules and often equally complex supportive care. Effective practice now requires that practitioners have quick access to reliable information that is both detailed and regimen-specific.
The Guide to Combination Cancer Chemotherapy Regimens provides in-depth and regimen-specific information on preparing, dispensing, and administering combination antineoplastic regimens. Regimens are grouped according to disease state and are accompanied by tables showing the recommended dosing schedules.
This easy-to-use format gives physicians, nurses, and pharmacists in all care delivery settings an indispensable and reliable tool for the practice of regimen-specific combination chemotherapy. This is also an excellent reference for the development of order sets. Additional information is provided on toxicities (both incidence and severity), supportive care, and monitoring associated with each regimen
Diseases Covered
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD AND NECK
LUNG
LEUKEMIAS
LYMPHOMAS
MELANOMA
MYELOMA
SARCOMAS
SOLID TUMORS
TUMORS OF UNKNOWN ORIGIN
About the Authors
Dominic A. Solimando, Jr, MA, FAPhA, FASHP,BCOP, is President of Oncology Pharmacy Services, Inc, and maintains a part-time clinical practice as an oncology pharmacist at Walter Reed Medical Center, Bethesda, Maryland.
J. Aubrey Waddell, PharmD, FAPhA, BCOP, is professor, University of Tennessee College of Pharmacy, Knoxville Campus, and oncology pharmacist, Blount Memorial Hospital, Maryville, Tennessee.
The Guide to Combination Cancer Chemotherapy Regimens provides in-depth and regimen-specific information on preparing, dispensing, and administering combination antineoplastic regimens. Regimens are grouped according to disease state and are accompanied by tables showing the recommended dosing schedules.
This easy-to-use format gives physicians, nurses, and pharmacists in all care delivery settings an indispensable and reliable tool for the practice of regimen-specific combination chemotherapy. This is also an excellent reference for the development of order sets. Additional information is provided on toxicities (both incidence and severity), supportive care, and monitoring associated with each regimen
Diseases Covered
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD AND NECK
LUNG
LEUKEMIAS
LYMPHOMAS
MELANOMA
MYELOMA
SARCOMAS
SOLID TUMORS
TUMORS OF UNKNOWN ORIGIN
About the Authors
Dominic A. Solimando, Jr, MA, FAPhA, FASHP,BCOP, is President of Oncology Pharmacy Services, Inc, and maintains a part-time clinical practice as an oncology pharmacist at Walter Reed Medical Center, Bethesda, Maryland.
J. Aubrey Waddell, PharmD, FAPhA, BCOP, is professor, University of Tennessee College of Pharmacy, Knoxville Campus, and oncology pharmacist, Blount Memorial Hospital, Maryville, Tennessee.
